# Cooling Plus Best Medical Treatment Versus Best Medical Treatment Alone for Acute Ischaemic Stroke

> **NCT01833312** · PHASE3 · TERMINATED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 98 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DEVICE:** Hypothermia
- **DRUG:** Buspirone
- **DRUG:** Pethidine

## Key facts

- **NCT ID:** NCT01833312
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2018-07-31
- **Final completion:** 2018-07-31
- **Target enrollment:** 98 (ACTUAL)
- **Why stopped:** Slow recruitment, cessation of funding
- **Last updated:** 2019-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01833312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01833312, "Cooling Plus Best Medical Treatment Versus Best Medical Treatment Alone for Acute Ischaemic Stroke". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT01833312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*